Previous studies identified a down-regulation of olfactory XRCC5, and FABP5 in initial AD stages, together with the overexpression of CD166 antigen, V-type proton ATPase subunit H, and histone H4 in advanced AD stages6. Here, ALCAM is linked to Alzheimer disease.